Consensus Development for Cardiothoracic Critical Care Training

Overseen By Jeremy Reeves

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: Ohio State University

Disqualifiers: Lack of experience

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 6

68 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve training for doctors caring for patients after heart and lung surgeries in intensive care. The goal is to develop a better training program by gathering input from experienced experts in this field. Participants should have at least five years of experience in cardiothoracic critical care and spend most of their time in intensive care units. As an unphased trial, this study offers participants the chance to contribute to advancements in medical training that could enhance patient care.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to establish cardiothoracic critical care as a distinct subspecialty, which could enhance the quality of care for patients with complex heart and lung conditions. Unlike the current treatment landscape, which often involves general critical care protocols, this approach focuses on developing specialized competencies and guidelines tailored specifically for cardiothoracic cases. By involving experts with roles in administration, education, and research, the trial seeks to define core competencies that could lead to more effective, targeted, and standardized care practices.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am an expert in Cardiothoracic Surgery Critical Care with over 5 years of experience.

I have completed a critical care fellowship in administration, education, or research.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase 1 Questioning

Phase 1 involves up to 3 rounds of questions to determine agreement or disagreement among experts

Approximately 3 months

Up to 3 rounds of surveys

Phase 2 Questioning

Phase 2 involves up to 3 rounds of questions to further refine consensus on training core competencies

Approximately 3 months

Up to 3 rounds of surveys

Follow-up

Participants are monitored for consensus achievement and further discussions if needed

6 months

What Are the Treatments Tested in This Trial?

Interventions

• Delphi Questionnaire

How Is the Trial Designed?

Group I: Delphi Panel Experimental Treatment 1 Intervention

Experts in the field of cardiothoracic critical care with administrative, educational, and research roles.

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials

891

Recruited

2,659,000+